Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Breast 5Thoracic 3Tumor-Agnostic 2Sarcoma 2Gynecologic 2Dermatologic 2Lymphoid 1Head & Neck 1Genitourinary 1CNS 1

Conditions

Neoplasm, Residual 1Neoplasm Metastasis 1

Interventions

pembrolizumab 26Specimen Handling 17Blood Specimen Collection 17Biopsy 16Magnetic Resonance Spectroscopy 15atezolizumab 11Surveys and Questionnaires 11Bevacizumab 9Radiotherapy 8Radiosurgery 8Nivolumab 8Fluorouracil 8Standard of Care 7Paclitaxel 7Irinotecan 7Gemcitabine 7Cisplatin 7olaparib 6durvalumab 6Palliative Care 6Oxaliplatin 6Leucovorin 6Cyclophosphamide 6Carboplatin 6Capecitabine 6alectinib 5abemaciclib 5Trastuzumab 5Interviews as Topic 5Exercise 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Liquid Biopsy × Tumor-Agnostic × Clear all
NCT06287749 2025-07-10

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

University Hospital, Montpellier

Recruiting
37 enrolled
Tumor-Agnostic

Neoplasm, Residual

NCT05283044 2025-06-25

PRISM-POrTAL

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Recruiting
10,000 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡